Skip to content

Patterns in public records, tested

Strategies

Explore the rules behind the ideas. Compare the evidence, open the details, and follow a strategy from signal to result.

Browse the strategies

Updated Oct 17

Strategies we test
23
plus 2 still gathering data
Solid evidence
None yet
beat similar stocks by more than luck
Firing now
18
of all 23, with an idea open today

A strategy’s big number is its edge over similar stocks in past tests; the smaller line is its average return over the stated hold (monthly strategies show an average month). Weekly Top 10 shows its total tracked return. Hypothetical results — not investment advice.

ThemeAll14Firing now11FDA & biotech4Fear & greed1
More filters · 1 changed
EvidenceSolid0Solid or some0All14
DirectionAll23Buy14Sell short8Buy + sell short1

Selling short uses borrowed shares to try to profit from a falling price.

SortBest edgeMost triesNewest idea

No rule has passed the publication check yet — here is what it takes

All strategies

Showing 14 of 23 strategies · buys · plus the Weekly Top 10 portfolio

Weekly Top 10Ten stocks. One rulebook.PortfolioLive recordTracked weekly, not a past testTracked total−10.1%Since Jul 15, 2026Through Oct 16, 2026

The weekly model portfolio, brought together in one strategy.

Ten stocks selected from public-record signals, set each Monday. Explore the current holdings, sector mix and recorded weekly history. Portfolio results are tracked separately from individual strategy tests.

Portfolio cycle

  1. Public signals
  2. 10-stock basket
  3. Rebalance weekly
Explore Weekly Top 10 Share
Nancy Pelosi's reported stock buysThe Speaker's StashDirection: Buy Research onlyNot yet validatedvs similar stocks+25.5 pp+40.1% avg. over 1 year, past tests

Buy when it fires · sell 1 year later

Research, not proof: the rule has not passed every check yet, including one on new trades.

Test sequence

  1. Buy it when it fires
  2. Hold 1 year
  3. Sell 1 year later

In past tests · each idea held 1 year

Each idea returned
+40.1%
on average
Vs similar stocks
25.5
percentage points better than similar stocks
Made money in
11 of 16
tries — too few to trust yet

10 open now · next sell Jan 26, 2027 · Congress trades

Explore strategy Share
3+ FDA approvals while markets are jumpyApprovals Through the ChaosDirection: Buy Waiting for source datesNot graded until re-testedvs similar stocks+8.6 pp+11.2% avg. over 3 months, past tests

Buy when it fires · sell 3 months later

These come from an older version of our test and are not graded until it is rerun.

Test sequence

  1. Buy it when it fires
  2. Hold 3 months
  3. Sell 3 months later

In past tests · each idea held 3 months

Each idea returned
+11.2%
on average
Vs similar stocks
8.6
percentage points better than similar stocks
Made money in
74 of 100
tries (74%)

Newest idea Apr 2 · FDA drug approvals

Explore strategy Share
3+ insiders buy after a 30% dropInsiders Buy the DipDirection: Buy Collecting forward evidencePast checks passedvs similar stocks+8.0 pp+17.3% avg. over 3 months, past tests

Buy when it fires · sell 3 months later

Its past tests passed our checks; now it must hold up on new trades.

Test sequence

  1. Buy it when it fires
  2. Hold 3 months
  3. Sell 3 months later

In past tests · each idea held 3 months

Each idea returned
+17.3%
on average
Vs similar stocks
8.0
percentage points better than similar stocks
Made money in
1,900 of 2,952
tries (64%)

60 open now · next sell Oct 18 · Insider filings

Explore strategy Share
Congress buys after a failed drug trialBuy the Trial FlopDirection: Buy Research onlyNot yet validatedvs similar stocks+5.9 pp+10.2% avg. over 6 months, past tests

Buy when it fires · sell 6 months later

Research, not proof: the rule has not passed every check yet, including one on new trades.

Test sequence

  1. Buy it when it fires
  2. Hold 6 months
  3. Sell 6 months later

In past tests · each idea held 6 months

Each idea returned
+10.2%
on average
Vs similar stocks
5.9
percentage points better than similar stocks
Made money in
51 of 73
tries (70%)

10 open now · next sell Jan 2, 2027 · Congress trades

Explore strategy Share
Insider buys 30% drop during market fearFear + Dip = BuyDirection: Buy Waiting for source datesNot graded until re-testedvs similar stocks+5.0 pp+12.3% avg. over 6 months, past tests

Buy when it fires · sell 6 months later

These come from an older version of our test and are not graded until it is rerun.

Test sequence

  1. Buy it when it fires
  2. Hold 6 months
  3. Sell 6 months later

In past tests · each idea held 6 months

Each idea returned
+12.3%
on average
Vs similar stocks
5.0
percentage points better than similar stocks
Made money in
464 of 901
tries (51%)

1 open now · next sell Oct 17 · Insider filings

Explore strategy Share
CFO buys $25K+ of own stockCFO ConvictionDirection: Buy Research onlyNot yet validatedvs similar stocks+3.6 pp+8.0% avg. over 3 months, past tests

Buy when it fires · sell 3 months later

Research, not proof: the rule has not passed every check yet, including one on new trades.

Test sequence

  1. Buy it when it fires
  2. Hold 3 months
  3. Sell 3 months later

In past tests · each idea held 3 months

Each idea returned
+8.0%
on average
Vs similar stocks
3.6
percentage points better than similar stocks
Made money in
1,315 of 2,178
tries (60%)

65 open now · next sell Oct 21 · Insider filings

Explore strategy Share
Senators' reported stock buysThe Senate TapeDirection: Buy Research onlyNot yet validatedvs similar stocks+3.5 pp+22.1% avg. over 1 year, past tests

Buy when it fires · sell 1 year later

Research, not proof: the rule has not passed every check yet, including one on new trades.

Test sequence

  1. Buy it when it fires
  2. Hold 1 year
  3. Sell 1 year later

In past tests · each idea held 1 year

Each idea returned
+22.1%
on average
Vs similar stocks
3.5
percentage points better than similar stocks
Made money in
1,395 of 1,904
tries (73%)

508 open now · next sell Oct 28 · Congress trades

Explore strategy Share
House member buys before a drug-trial updateLab Coats & LawmakersDirection: Buy Collecting forward evidencePast checks passedvs similar stocks+2.9 pp+5.4% avg. over 3 months, past tests

Buy when it fires · sell 3 months later

Its past tests passed our checks; now it must hold up on new trades.

Test sequence

  1. Buy it when it fires
  2. Hold 3 months
  3. Sell 3 months later

In past tests · each idea held 3 months

Each idea returned
+5.4%
on average
Vs similar stocks
2.9
percentage points better than similar stocks
Made money in
146 of 196
tries (74%)

10 open now · next sell Nov 8 · ClinicalTrials.gov events

Explore strategy Share
Buy when a major drug trial completesBuy Drugmakers When a Major Drug Trial FinishesDirection: Buy Research onlyNot yet validatedvs similar stocks+2.5 pp+7.5% avg. over 3 months, past tests

Buy when it fires · sell 3 months later

Research, not proof: the rule has not passed every check yet, including one on new trades.

Test sequence

  1. Buy it when it fires
  2. Hold 3 months
  3. Sell 3 months later

In past tests · each idea held 3 months

Each idea returned
+7.5%
on average
Vs similar stocks
2.5
percentage points better than similar stocks
Made money in
38 of 62
tries (61%)

17 open now · next sell Oct 21 · ClinicalTrials.gov events

Explore strategy Share
Buy new spin-offs after their first weekBuy New Spin-Offs After Their First WeekDirection: Buy Research onlyNot yet validatedvs similar stocks+2.2 pp+5.3% avg. over 3 months, past tests

Buy when it fires · sell 3 months later

Research, not proof: the rule has not passed every check yet, including one on new trades.

Test sequence

  1. Buy it when it fires
  2. Hold 3 months
  3. Sell 3 months later

In past tests · each idea held 3 months

Each idea returned
+5.3%
on average
Vs similar stocks
2.2
percentage points better than similar stocks
Made money in
52 of 95
tries (55%)

2 open now · next sell Nov 9 · Spin-offs

Explore strategy Share
Companies with a federal lobbying filingAt the TroughDirection: Buy Research onlyNot yet validatedvs similar stocks+2.0 pp+6.0% avg. over 3 months, past tests

Buy when it fires · sell 3 months later

Research, not proof: the rule has not passed every check yet, including one on new trades.

Test sequence

  1. Buy it when it fires
  2. Hold 3 months
  3. Sell 3 months later

In past tests · each idea held 3 months

Each idea returned
+6.0%
on average
Vs similar stocks
2.0
percentage points better than similar stocks
Made money in
2,889 of 5,014
tries (58%)

338 open now · next sell Oct 18 · Lobbying

Explore strategy Share
CFO buys $25K+ of own liquid stockCFO Conviction, LiquidDirection: Buy Research onlyNot yet validatedvs similar stocks+2.0 pp+6.6% avg. over 3 months, past tests

Buy when it fires · sell 3 months later

Research, not proof: the rule has not passed every check yet, including one on new trades.

Test sequence

  1. Buy it when it fires
  2. Hold 3 months
  3. Sell 3 months later

In past tests · each idea held 3 months

Each idea returned
+6.6%
on average
Vs similar stocks
2.0
percentage points better than similar stocks
Made money in
862 of 1,426
tries (60%)

47 open now · next sell Oct 21 · Insider filings

Explore strategy Share
Earnings up 30%+ from a year agoYoY MonsterDirection: Buy Research onlyNot yet validatedvs similar stocks+1.0 pp+1.7% avg. over 3 months, past tests

Buy when it fires · sell 3 months later

Research, not proof: the rule has not passed every check yet, including one on new trades.

Test sequence

  1. Buy it when it fires
  2. Hold 3 months
  3. Sell 3 months later

In past tests · each idea held 3 months

Each idea returned
+1.7%
on average
Vs similar stocks
1.0
percentage points better than similar stocks
Made money in
344 of 679
tries (51%)

Newest idea Apr 1 · Company financials

Explore strategy Share
Follow rising trends across stocks, bonds, goldRide Every TrendDirection: Buy Needs a fresh testNot graded until re-testedvs similar stocks, a month−0.1 pp+0.7% in an average month, past tests

Re-picked every month

These come from an older version of our test and are not graded until it is rerun.

Test sequence

  1. Pick the basket each month
  2. Hold 1 month
  3. Re-pick next month

In past tests · a basket re-picked every month

It returned
+0.7%
in an average month
Vs similar stocks
0.1
percentage points worse than similar stocks, a month
Made money in
63 of 133
tries (47%)

Newest idea Oct 1 · Stock prices

Explore strategy Share

Go deeper

Our track record →The ideas we show, tracked from the day we first show them — misses included.How we test →Each idea is measured against similar stocks over a fixed hold. Here is how the grade works.Combine rules yourself →Mix our strategies in the Strategy Lab and get the same honest grade.Compare strategies →Put two or three side by side: grades, numbers and shared trades.

Hypothetical, not investment advice. Each position is opened at the next trading day’s close after the record became public and held for the stated time. Sell short ideas assume borrowed shares are sold, then bought back to close. Past results do not predict future results.